Alemtuzumab: The advantages and challenges of a novel therapy in MS

Title
Alemtuzumab: The advantages and challenges of a novel therapy in MS
Authors
Keywords
-
Journal
NEUROLOGY
Volume 83, Issue 1, Pages 87-97
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-06-12
DOI
10.1212/wnl.0000000000000540

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started